Cardiac Involvement in COVID-19

Cardiac Involvement in COVID-19 Guest: Patricia A. Pellikka, M.D. (@pattypellikka) Host: Paul A. Friedman, M.D. (@drpaulfriedman) Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19. Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: Significance of cardiac involvement in patients with COVID-19 Diagnosis of cardiac dysfunction in patients with COVID-19 Myocarditis and other cardiac injury in patients with COVID-19 Implications of MRI-identified myocarditis COVID-19 long-haulers and cardiac evaluation Artificial intelligence in electrocardiogram or echocardiogram Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. No CME credit offered for this episode. Podcast episode transcript here.